2家供應(yīng)商在售
|
||||||
商品名稱 | 規(guī)格 | 代理級(jí)別 | 價(jià)格 | 運(yùn)費(fèi) | 供應(yīng)商 | 購(gòu)買 |
Stathmin Antibody
交貨周期:現(xiàn)貨
|
20 μl | 經(jīng)銷 |
登錄可見
|
- |
北京敏泰元科技有限公司 |
庫(kù)存:20
|
CST 3352T Stathmin Antibody
交貨周期:部分現(xiàn)貨,期貨3-4周左右,優(yōu)質(zhì)售后
|
20μl | 經(jīng)銷 |
登錄可見
|
- |
上海優(yōu)寧維生物科技股份有限公司 |
庫(kù)存:998
|
REACTIVITY | H M R Mk |
SENSITIVITY | Endogenous |
MW (kDa) | 19 |
SOURCE | Rabbit |
Application | Dilution |
---|---|
Western Blotting | 1:1000 |
Immunohistochemistry (Paraffin) | 1:50 |
Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 μg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.
Stathmin Antibody detects endogenous levels of total stathmin protein. The antibody does not cross-react with related proteins such as SCG10, SCLIP and RB3.
Human, Mouse, Rat, Monkey
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ser38 of human stathmin. Antibodies are purified by protein A and peptide affinity chromatography.
Stathmin is a ubiquitously expressed microtubule destabilizing phosphoprotein that is upregulated in a number of cancers. The amino terminus of the protein contains multiple phosphorylation sites and is involved in the promotion of tubulin filament depolymerization. Phosphorylation at these sites inactivates the protein and stabilizes microtubules. Ser16 phosphorylation by CaM kinases II and IV (1,2) increases during G2/M-phase and is involved in mitotic spindle regulation (3,4). Ser38 is a target for cdc2 kinase (5) and TNF-induced cell death gives rise to reactive oxygen intermediates leading to hyperphosphorylation of stathmin (6). EGF receptor activation of Rac and cdc42 also increases phosphorylation of stathmin on Ser16 and Ser38 (7). Other closely related family members are neuronally expressed and include SCG10, SCLIP, RB3 and its splice variants RB3' and RB3''. Stathmin and SCG10 have been shown to play roles in neuronal-like development in PC-12 cells (8).
商城介紹 | 媒體報(bào)道 | 法規(guī)政策 | 協(xié)議專區(qū)
京公網(wǎng)安備 11010802025067號(hào) 增值電信業(yè)務(wù)經(jīng)營(yíng)許可證:京B2-20171454 ICP備案號(hào):京ICP備16050672號(hào)-1
喀斯瑪科技版權(quán)所有 2017-
藥品醫(yī)療器械網(wǎng)絡(luò)信息服務(wù)備案: (京)-網(wǎng)藥械信息備字(2022)第00393號(hào)
醫(yī)療器械網(wǎng)絡(luò)交易服務(wù)第三方平臺(tái)備案編號(hào):京網(wǎng)械平臺(tái)備字(2021)第00006號(hào)
網(wǎng)絡(luò)食品交易第三方平臺(tái)提供者備案 :京食藥網(wǎng)食備202110062 信息系統(tǒng)安全等級(jí)保護(hù)備案證明(三級(jí))